Cargando…

The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment

BACKGROUND AND OBJECTIVE: A reliable noninvasive prediction tool for the screening, diagnosis, and/or staging of colorectal cancer (CRC) before surgery is critical for the choice of treatment and prognosis. METHODS: Patients admitted for initial treatment of CRC between January 1, 2015, and December...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Feng, Qu, Di, Sun, Ruya, Tao, Han, Si, Junru, Xu, Yuqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766087/ https://www.ncbi.nlm.nih.gov/pubmed/31636738 http://dx.doi.org/10.1155/2019/7152183

Ejemplares similares

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

A long noncoding RNA positively regulates CD56 in human natural killer cells
por: Zhang, Ruya, et al.
Publicado: (2016)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

The involvement of circulating CD69(+) CD56(bright) natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
por: Chikuie, Emi, et al.
Publicado: (2023)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity
por: Briones, Melissa R, et al.
Publicado: (2017)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Beyond Uterine Natural Killer Cell Numbers in Unexplained Recurrent Pregnancy Loss: Combined Analysis of CD45, CD56, CD16, CD57, and CD138
por: Chiokadze, Maia, et al.
Publicado: (2020)

Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis
por: Kullberg, Susanna, et al.
Publicado: (2021)

CD56(dim) CD16(−) Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
por: Vujanovic, Lazar, et al.
Publicado: (2019)

Key Role of the CD56(low)CD16(low) Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells
por: Vulpis, Elisabetta, et al.
Publicado: (2018)

Circulating NKG2A–NKG2D+ CD56dimCD16+ Natural Killer (NK) Cells as Mediators of Functional Immunosurveillance in Kidney Transplant Recipients
por: Zhu, Li, et al.
Publicado: (2020)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells
Publicado: (1993)

Increased early activation of CD56(dim)CD16(dim/-) natural killer cells in immunological non-responders correlates with CD4(+) T-cell recovery
por: Zhang, Qiu-Yue, et al.
Publicado: (2020)

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56(dim)CD16(+) and CD56(bright)CD16(dim/−) natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Huth, Teilah Kathryn, et al.
Publicado: (2016)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides
por: Merkt, Wolfgang, et al.
Publicado: (2021)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells
Publicado: (1991)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2018)

Endometrial CD56+ natural killer cells in women with recurrent implantation failure: An immunohistochemical study
por: Babayeva, Gulchin, et al.
Publicado: (2020)

The upregulation of peripheral CD3(-)CD56(+)CD16(+) natural killer cells correlates with Th1/Th2 imbalance in asthma patients during acute upper respiratory viral infections
por: Liu, Meixuan, et al.
Publicado: (2023)

Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56(dim) Natural Killer Cells
por: Lajoie, Laurie, et al.
Publicado: (2017)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3(+)CD8(+)CD56(+) Natural Killer T Population in Women with Recurrent Spontaneous Abortion
por: Rezayat, Fatemeh, et al.
Publicado: (2023)

Altered phenotypic and metabolic characteristics of FOXP3(+)CD3(+)CD56(+) natural killer T (NKT)-like cells in human malignant pleural effusion
por: Wang, Zi-Hao, et al.
Publicado: (2022)

Enriched CD45RA(−)CD62L(+) central memory T and decreased CD3(+)CD56(+) natural killer T lymphocyte subsets in the rectum of ulcerative colitis patients
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Primary gastric natural killer/T-cell lymphoma with diffuse CD30 expression and without CD56 expression: A case report
por: ZHANG, LIZHI, et al.
Publicado: (2016)

Alterations in CD8(+) Tregs, CD56(+) Natural Killer Cells and IL-10 Are Associated With Invasiveness of Nonfunctioning Pituitary Adenomas (NFPAs)
por: Huang, Xinmei, et al.
Publicado: (2021)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
por: Laroni, Alice, et al.
Publicado: (2020)

High CD56(++)CD16(-) natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort
por: Bayigga, Lois, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_10vs13vgtigd1ck09ime0sq77q